- Vincent H F Mak, consultant physician1
- On behalf of the NHS London Respiratory Team Programme Board
- 1Central Middlesex Hospital, London NW10 7NS, UK
Mackenzie highlights the lack of guidance on use of inhaled corticosteroids (ICS) and risk of adrenal suppression.1 The Medicines and Healthcare Products Regulatory Agency recommends issuing a steroid treatment card,2 but there is concern that this may alarm patients and reduce adherence. There is also no consensus on what constitutes a high dose.
High potency combination inhalers (ICS …